RUA Life Sciences plc – LSE:RUA.L

RUA Life Sciences stock price today

GBP 75
+64
+581.82%
Financial Health
0
1
2
3
4
5
6
7
8
9

RUA Life Sciences stock price monthly change

-1.87%
month

RUA Life Sciences stock price quarterly change

-1.87%
quarter

RUA Life Sciences stock price yearly change

+11.79%
year

RUA Life Sciences key metrics

Market Cap
6.53M
Enterprise value
8.90M
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
0.01
PEG ratio
N/A
EPS
-0.15
Revenue
3.43M
EBITDA
-3.67M
Income
-3.39M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
-107.21%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

RUA Life Sciences stock price history

RUA Life Sciences stock forecast

RUA Life Sciences financial statements

RUA Life Sciences plc (LSE:RUA.L): Profit margin
Dec 2021 458.5K -378K -82.44%
Sep 2022 1.10M -1.14M -103.53%
Mar 2023 1.07M -860K -80%
Sep 2023 794K -1.01M -127.2%
RUA Life Sciences plc (LSE:RUA.L): Analyst Estimates
2026 4.27M 435K 10.18%
  • Analysts Price target

  • Financials & Ratios estimates

RUA Life Sciences plc (LSE:RUA.L): Debt to assets
Jun 2022 6597000 1.11M 16.84%
Sep 2022 6597000 1.11M 16.84%
Dec 2022 5663000 980K 17.31%
Sep 2023 4754000 1.02M 21.46%
RUA Life Sciences plc (LSE:RUA.L): Cash Flow
Sep 2021 -1.10M -397K -31K
Sep 2022 -470K -94K 110K
Mar 2023 -704K -355K 22K
Sep 2023 -904K -42K -30K

RUA Life Sciences alternative data

RUA Life Sciences plc (LSE:RUA.L): Employee count
Aug 2023 38
Sep 2023 38
Oct 2023 48
Nov 2023 48
Dec 2023 48
Jan 2024 48
Feb 2024 48
Mar 2024 48
Apr 2024 48
May 2024 48
Jun 2024 48
Jul 2024 48

RUA Life Sciences other data

Insider Compensation
Mr. William Donald Brown (1964) Executive Chairman & Fin. Director
$182,880
Dr. Caroline Stretton (1971) Group MD & Director
$108,680
Mr. John McKenna (1953) Director of Clinical Marketing & Executive Director $52,250
  • What's the price of RUA Life Sciences stock today?

    One share of RUA Life Sciences stock can currently be purchased for approximately $75.

  • When is RUA Life Sciences's next earnings date?

    Unfortunately, RUA Life Sciences's (RUA.L) next earnings date is currently unknown.

  • Does RUA Life Sciences pay dividends?

    No, RUA Life Sciences does not pay dividends.

  • How much money does RUA Life Sciences make?

    RUA Life Sciences has a market capitalization of 6.53M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 34.83% to 2.19M US dollars.

  • What is RUA Life Sciences's stock symbol?

    RUA Life Sciences plc is traded on the LSE under the ticker symbol "RUA.L".

  • What is RUA Life Sciences's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of RUA Life Sciences?

    Shares of RUA Life Sciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are RUA Life Sciences's key executives?

    RUA Life Sciences's management team includes the following people:

    • Mr. William Donald Brown Executive Chairman & Fin. Director(age: 61, pay: $182,880)
    • Dr. Caroline Stretton Group MD & Director(age: 54, pay: $108,680)
    • Mr. John McKenna Director of Clinical Marketing & Executive Director(age: 72, pay: $52,250)
  • How many employees does RUA Life Sciences have?

    As Jul 2024, RUA Life Sciences employs 48 workers.

  • When RUA Life Sciences went public?

    RUA Life Sciences plc is publicly traded company for more then 28 years since IPO on 26 Feb 1997.

  • What is RUA Life Sciences's official website?

    The official website for RUA Life Sciences is rualifesciences.com.

  • How can i contact RUA Life Sciences?

    RUA Life Sciences can be reached via phone at +44 1294 317073.

RUA Life Sciences company profile:

RUA Life Sciences plc

rualifesciences.com
Exchange:

LSE

Full time employees:

40

Industry:

Medical - Devices

Sector:

Healthcare

RUA Life Sciences plc, together with its subsidiaries, provides polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates as a contract developer and manufacturer of medical devices; and licensor of Elast-Eon and ECSil implantable co-polymers that are used in cardiology and urological applications, including pacing leads, cardiac cannulae, and stent devices, as well as reaction injection molding technology for use in high-precision medical device components. It also develops bore polymer sealed grafts and soft tissue patches; and tri leaflet polymeric heart valves. The company was formerly known as AorTech International plc and changed its name to RUA Life Sciences plc in June 2020. RUA Life Sciences plc was incorporated in 1996 and is headquartered in Irvine, the United Kingdom.

2 Drummond Crescent
Irvine, KA11 5AN

:
ISIN: GB0033360586
CUSIP: G0402P119